A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia

Archive ouverte

Mercadal, Lucile | Metzger, Marie | Haymann, Jean-Philippe | Thervet, Eric | Boffa, Jean-Jacques | Flamant, Martin | Vrtovsnik, François | Gauci, Cédric | Froissart, Marc | Stengel, Bénédicte

Edité par CCSD ; Public Library of Science -

on behalf of the NephroTest Study Group. International audience. BackgroundIron disorders are common and complex in chronic kidney disease (CKD). We sought to determine whether a 3-marker index would improve the classification of iron disorders in CKD anaemia.MethodsWe studied the association between Hb level and iron indexes combining 2 or 3 of the following markers: serum ferritin (<40 ng/mL), transferrin saturation (TSAT<20%) and total iron binding capacity (TIBC<50 µmol/L) in 1011 outpatients with non-dialysis CKD participating in the Nephrotest study. All had glomerular filtration rates measured (mGFR) by 51Cr-EDTA renal clearance; 199 also had hepcidin measures.ResultsThe TSAT-TIBC-ferritin index explained Hb variation better than indexes combining TSAT-TIBC or ferritin-TSAT. It showed hypotransferrinaemia and non-inflammatory functional iron deficiency (ID) to be more common than either absolute or inflammatory ID: 20%, 19%, 6%, and 2%, respectively. Hb was lower in all abnormal, compared with normal, iron profiles, and decreased more when mGFR was below 30 mL/min/1.73 m2 (interaction p<0.0001). In patients with mGFR<30 mL/min/1.73 m2, the Hb decreases associated with hypotransferrinaemia, non-inflammatory functional ID, and absolute ID were 0.83±0.16 g/dL, 0.51±0.18 and 0.89±0.29, respectively. Compared with normal iron profiles, hepcidin was severely depressed in absolute ID but higher in hypotransferrinaemia.ConclusionsThe combined TSAT-TIBC-ferritin index identifies hypotransferrinaemia and non-inflammatory functional ID as the major mechanisms of iron disorders in CKD anaemia. Both disorders were associated with a greater decrease in Hb when mGFR was <30 mL/min/1.73 m2. Taking these iron profiles into account may be useful in stratifying patients in clinical trials of CKD anaemia and might improve the management of iron therapy.

Suggestions

Du même auteur

Timing and determinants of erythropoietin deficiency in chronic kidney disease.. Timing and determinants of erythropoietin deficiency in chronic kidney disease.: Erythropoietin and chronic kidney disease

Archive ouverte | Mercadal, Lucile | CCSD

International audience. BACKGROUND AND OBJECTIVES: Anemia in patients with CKD is highly related to impaired erythropoietin (EPO) response, the timing and determinants of which remain unknown. DESIGN, SETTING, PARTI...

Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease

Archive ouverte | Michon-Colin, Arthur | CCSD

International audience. ABSTRACT Background Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this...

Association of a Low-Protein Diet With Slower Progression of CKD

Archive ouverte | Metzger, Marie | CCSD

Open access article. International audience. Introduction: Reducing protein intake is recommended for slowing chronic kidney disease (CKD) progression, but assessment of its true effectiveness is sparse. Methods: Us...

Chargement des enrichissements...